A recent report filed by top senators has asked the State Department to explain how the billions in funding that was injected into various counter-narcotics programs across Latin America were used, as these programs haven’t yielded results. The report also calls out the federal government over the failed war on drugs.

The report is part of the bill to finance the federal government that Chairman Patrick Leahy of the Senate Appropriations Committee introduced a couple of days ago.

The panel stated that the incidence of corruption and violence related to drug trafficking in Latin America has increased steadily since the 1980s when various counter-narcotics programs were introduced. The use and availability of illicit drugs in the United States is also high. The panel noted that despite these failures, the strategies used by different U.S. administrations since the inception of these programs remain unchanged.

The report directs the secretary of state to compile and present a report that assesses the reasons why prior efforts haven’t met the expectations as well as the cost-benefit analysis of previous counter-narcotics initiatives in Mexico, Central America, Colombia, Bolivia and Peru.

The committee is also seeking a description of the objectives and projected results of the present strategy, how the present strategy is different from past efforts and any necessary changes in the United States domestic counter-narcotics policies. This, it stated, would allow strategies that decrease the production and trafficking of illegal drugs and related corruption and violence in Latin America to succeed.

This draft Appropriations Committee report will be attached to the 2022 fiscal year spending bill for the Department of State, Foreign Operations and Related Programs. It remains unclear when the measures will be considered and officially approved by the panel.

If the measure is enacted, it would allow Washington D.C. to legalize recreational cannabis sales. It would also encourage the development of technologies that can identify THC-impaired driving and request the federal government to reconsider policies that require employees be fired for marijuana use. In addition, the measure criticizes the current restrictive system for classifying drugs, which hinders scientific research on marijuana.

Rep. Alexandria Ocasio-Cortez introduced a similar amendment in the House’s version of the spending legislation, which was recently passed. The measure calls for banning the use of funds for aerial fumigation on illicit crops in Colombia. Aerial fumigation has been widely criticized by human rights and reform advocates.

The step taken by the Senate committee could trigger a rethink of the country’s drug policies and maybe even kick-start a process through which cannabis may be rescheduled federally, ending one of the biggest hurdles that the industry and its sector players, such as Hero Technologies Inc. (OTC: HENC), have had to navigate.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan as part of its ongoing commitment to position itself as a multistate operator in the cannabis sector. Its BlackBox Systems and Technologies LLC subsidiary fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan and received step 1 prequalification approval for a Class C Adult-Use cannabis license. “With those approvals in hand, Hero Technologies and BlackBox are now beginning the next — and last — step in the process of obtaining licensing approval in Michigan: establishment use or full license approval for a newly constructed medical marijuana facility, which will allow HENC to move forward with its plans for cultivation of cannabis in Michigan,” reads a recent article. “In addition to its Michigan expansion plans, Hero Technologies is undertaking expansion in Colorado through its wholly owned subsidiary Mile High Green LLC… HENC is also planning to expand in Massachusetts through its wholly owned subsidiary MassCannabis LLC. In addition, Hero Technologies owns and operates two hemp websites: HighlyRelaxing.com under Highly Relaxing LLC and VeteranHempCo.com.”

To view the full article, visit https://cnw.fm/8F6gr

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Marijuana businesses have been unable to access financial services such as deposit accounts, cashless payments and loans since legal sales began in America. This is mostly due to the controversial plant’s classification as a Schedule I controlled drug, and it has had wide-ranging consequences on both cannabis businesses and federal authorities.

Players in the cannabis space are forced to transact on a cash-only basis, increasing their chances of robberies and making it difficult to account for and pay taxes. Furthermore, federal authorities, the IRS specifically, don’t often receive taxes that are due, and when they do, it is usually in large amounts of cash.

For quite a while, stakeholders, drug reform activists and lawmakers have urged federal authorities to allow cannabis businesses to access banking services. Recently, a top IRS official joined the growing number of figures that support banking services for America’s state-legal cannabis industry after she claimed that cannabis banking reform would ease the taxman’s work.

The IRS would like to get paid, IRS official Cassidy Collins said during an event hosted by UCLA’s Annual Tax Controversy Institute, and granting marijuana access to the banking system will be a big help. As it stands, marijuana presents a “special type of collection challenge” since the plant is federally outlawed and mostly stuck to cash-only payments that make it harder for the federal agency to receive taxes from cannabis businesses, Cassidy says.

She notes that the cash-only payment crisis can be attributed to two things: customers that are avoiding a paper trail that shows they purchased cannabis and banks that avoid working with cannabis businesses due to fear of reprisal by the federal government. Fortunately, lawmakers have introduced cannabis reform bills to give the industry access to banking services, and one of them has made headway.

Cassidy, a senior counsel in the IRS Office of Chief Counsel, says that while her views on cannabis banking may not represent the IRS’s or her own opinion, it would make the agency’s job of collecting taxes a lot easier. The Internal Revenue Service’s main objective, after all, is to collect taxes, and any legislation that eases the agency’s efforts is welcome.

Currently, cannabis business operators have to visit IRS tax assistance centers, which accept cash payments greater than $50,000. However, Cassidy notes that an operator will likely spend some time at the center because the federal employee has to check and double-check payments. The agency wants to work with companies in the cannabis space, regardless of the plant’s status with the federal government, to ensure it gets paid the taxes owed. Should lawmakers finally pass cannabis legislation, both cannabis companies and the IRS stand to benefit.

Cannabis banking reform will not only benefit the IRS but will also remove a major bottleneck faced by the entire marijuana industry, including sector players such as Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Despite being one of the youngest sectors in the country, the United States’ state-legal cannabis industry has been dubbed the fastest growing industry in the country. Cannabis companies have generated billions of dollars in revenue in the few years cannabis has been legal, providing hundreds of thousands of job opportunities and filling state coffers with millions in cannabis tax revenue.

The industry is projected to undergo exponential growth in the next couple of years, pulling in a whopping $43 billion in legal cannabis sales by 2025. However, cannabis could not have gotten to where it is so far without technological advancements that have made cultivating and processing the plant a lot more efficient, and experts predict that technology will play a significant role in the industry’s growth.

Software-based technology will be especially critical to cannabis businesses moving forward. As it is, most players in the cannabis space cannot access financial services such as wireless payments and loans as the murky regulatory space has kept financial providers away. Fintech company KindTap is the first company to offer a credit payment option for businesses in the cannabis space, first launching in Massachusetts before going to other U.S. markets, including Florida, Maine, and New York by the end of the year.

KindTap provides revolving credit lines for upfront purchases and a credit payment system for businesses. Cathy Corby Iannuzzelli, an executive at KindTap, joined the fintech after she noticed cashless payments were virtually nonexistent in the cannabis industry while working for a client in Denver.

Compared to other industries, cannabis barely has a comprehensive regulatory structure and runs on a patchwork of state policies, and this often results in a pile of bureaucracy and paperwork, especially for multistate operators that have to keep track of different policies and requirements in different states. It will likely be some time before lawmakers federally decriminalize cannabis and finally fix the mess that is America’s cannabis industry, but in the meantime, companies have to adhere to current policies.

Simplifya, a Denver-based cannabis compliance software provider, has developed software that ensures cannabis businesses stay compliant amid a fragmented regulatory environment. The operational compliance software automates complex processes and boasts badge tracking, tailored reporting, SOPs and employee accountability features.

Springbig, a customer loyalty and text message communications provider, has developed a single source of truth customer relationship management (“CRM”) that acts as a database to record in store and online purchases. It can also capture key purchasing and behavioral data, integrate with existing dispensary POS and eCommerce systems seamlessly. These are just a few examples of the companies that have studied the market and developed software-based solutions for many of the issues that plague cannabis. As the industry becomes larger and draws more clientele, technology will be instrumental in achieving marijuana’s maximum potential.

Given the pace at which the industry is evolving, many cannabis companies, including Hero Technologies Inc. (OTC: HENC), are putting technology at the core of their operations in order to gain an edge over other sector actors.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Over the past couple of years, cannabis has grown increasingly popular as more states pass legislation to allow either medical marijuana or recreational cannabis. With advocates across the country advocating for state measures and lawmakers discussing federal decriminalization, cannabis has come a long way from the days of prohibition.

As it has slowly shed its unfounded reputation as a destructive drug, cannabis has interestingly moved into the health and wellness space thanks to a diverse range of purported health benefits. By May 2018, more than 3.5 million registered medical marijuana patients existed across the country, with countless more using recreational marijuana to try and alleviate their health issues.

However, despite cannabis’ popularity as a medical alternative, most scientists caution that the hype has far outpaced the science. While marijuana definitely has medical potential, using it as an alternative to pharmaceuticals, especially without the knowledge and permission of a doctor, can be quite dangerous. According to recently published research, such a situation is unfolding in America among individuals suffering from breast cancer. The study, which was published in “Cancer,” an American Cancer Society peer-reviewed journal, found that nearly half of American adults suffering from breast cancer use marijuana alongside their treatment to manage side effects and symptoms.

Various types of cancer and their treatments often cause pain, fatigue, insomnia, nausea and other health issues. Although studies have found that cannabis can indeed alleviate issues such as chronic pain, lack of appetite and insomnia, many physicians are not comfortable discussing it as a treatment option due to the limited knowledge on cannabis’ risks and benefits.

To find the rate of cannabis use among breast cancer patients, the researchers conducted an online survey of 612 participants. An estimated 42% of respondents said they had used cannabis to treat symptoms such as pain, insomnia, anxiety, nausea and vomiting with 75% of those who used cannabis reporting that it was extremely or very helpful.

Disturbingly, 49% of the participants who used marijuana believed medical cannabis could treat cancer, a claim that is still unproven by scientists. Almost 80% of the cannabis users had taken cannabis while undergoing other treatments such as surgery, radiation and systemic therapies. Half of those patients had looked for information on medical cannabis with websites and other patients being the most popular sources of information and physicians being the least popular. Most of the respondents were not satisfied with the information they received on medical cannabis. Furthermore, participants used cannabis products of varying quality and purity, mistakenly assuming that the products were safe and tested.

The researchers concluded that health providers ought to initiate informed conversations about medical marijuana with their patients. The fact that cancer patients are using cannabis without their doctors’ knowledge is a “major blind spot” in ability of health-care providers to provide suitable care, the researchers say. Initiating informed conversations will allow doctors to properly manage the symptoms and side effects of cancer and cancer treatment while minimizing potential side effects and treatment interactions.

The findings that plenty of women are using marijuana alongside their prescription medications seems to reaffirm how much the public has come to trust medicinal cannabis products such as those made by companies such Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

In late 2019, the United States was rocked by an outbreak of severe lung illness that took 68 lives and left an estimated3,000 individuals with ill health. Authorities soon found out that the cause of this lung disease breakout was illegal black market cannabis vaping products containing vitamin E acetate, a synthetic form of vitamin E that was used as a thickening agent. Dubbed e-cigarette and vaping-associated lung injury (“EVALI”), the outbreak led to the pull-out of several cannabis products with artificial thickening agents such as vitamin E acetate. In addition, regulators are thinking of banning the use of such additives in cannabis products.

Now, a new federally funded study looking at the relationship between the prevalence of EVALI and state cannabis policies has revealed that the outbreak was significantly less severe in states with legal cannabis markets. Published in the “Drug and Alcohol Dependence” journal, the study found that EVALI was less prevalent in states where adult-use cannabis was legal or where medical marijuana patients were allowed to grow their own cannabis. States with recreational cannabis markets had 42% fewer EVALI cases, the National Institute on Drug Abuse-funded study revealed, while those that had medical marijuana markets where home cultivation was allowed had 60% lower EVALI incidence compared to medical marijuana states that didn’t allow home cultivation.

The report concluded that while there was a relationship between recreational marijuana laws and reduced EVALI incidence, the incidence of lung disease in medical marijuana states depended on “their policy attributes.” The states that had the highest EVALI incidence had either banned cannabis use outright or had medical cannabis industries that didn’t allow for home cultivation.

Penned by Abigail Friedman, a professor at Yale School of Public Health, and Megan Morean, a psychiatry research student at the Yale School of Medicine, the report is further proof of what cannabis reform activists have been saying: a legal cannabis market where products are regulated and tested for safety is much better than outright prohibition.

Outlawing cannabis will not reduce the demand; it will rather provide an avenue for black-market players to step in and provide products that are neither regulated nor tested for safety. And as we saw from the EVALI outbreak, it is the public that pays the ultimate price when there are no legal, registered sellers. As the report states, public demand for illicit products will decrease if consumers can obtain the substance legally from reputable sellers.

This research provides further proof that sector player such as Hero Technologies Inc. (OTC: HENC) aren’t only in business for profit but also indirectly protect public health.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

A report has found that about 320,000 Americans are working in the cannabis industry. This represents a more than 30% increase from 2020 figures, making cannabis one of the country’s fastest-growing sectors. This also means that the United States has more legal marijuana workers than electrical engineers, paramedics or dentists.

The marijuana industry has grown significantly since last year when cultivation facilities and dispensaries were classified as essential businesses by various states at the onset of the coronavirus pandemic.

Published in partnership with Whitney Economics, the Leafly Jobs Report shows that in 2020, the industry added about 80,000 jobs to the market, which is almost twice what it added in 2019. It helps that more states across the country are also legalizing the use of the plant for both recreational and medical purposes.

Some Americans are re-evaluating their career prospects and jobs after the pandemic remodeled their working and social lives. Many are quitting their jobs in search of more opportunities for advancement, better benefits and consistent hours, which can be found in the legal marijuana industry.

Viridian Staffing chief executive of cannabis recruiting Kara Bradford stated that a shift of workers from restaurants and retail to marijuana has been observed, noting that there’s a sense that the industry has a lot of opportunities for advancement. The surge in marijuana hiring has put pressure on other employers to ease drug-testing requirements, especially in the District and the eighteen states where recreational cannabis use is legal. This is in addition to increasing pay, as the hourly rate at dispensaries is between $12 and $15.

Earlier in June, the second-biggest private employer in the country, Amazon, announced that it would support federal measures to legalize cannabis and stop screening employees for marijuana use. Other employers, including city governments, restaurants and retailers, have also removed these requirements in an attempt to attract workers in the current labor market where employment opportunities exceed the number of unemployed Americans.

Workers’ rights groups are also calling for broader unionization in the marijuana industry, noting that it is a crucial time to establish well-paying jobs that have proper protections. They assert that the marijuana industry could become a pipeline to middle-class jobs, with the right policies.

Cowen, a Wall Street research firm, revealed that sales of legal marijuana grew to $19 billion in 2020, which equates to an almost 60% increase. By 2025, the industry’s sales are expected to hit $41 billion.

Those growing employment figures take on an added meaning when one considers the rate at which companies such as Hero Technologies Inc. (OTC: HENC) are expanding and taking on new employees.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Hero Technologies (OTC: HENC), a cannabis company, and its subsidiary BlackBox Systems and Technologies LLC, has received step 1 prequalification approval for a class C adult-use cannabis license in the state of Michigan. The company also fulfilled the requirements for step 1 prequalification approval to receive a class C medicinal use cannabis license in Michigan. With these steps taken, the company now plans to start the process for step 2 establishment use or full license approval for a newly constructed medical marijuana facility. According to the announcement, once Hero Technologies completes step 2 with the Michigan Marijuana Regulatory Agency (“MRA”), it has already obtained approval from the township of Pulaski for three class C medicinal use cannabis licenses. When the company completes construction on the planned greenhouses and obtains a certificate of occupancy, along with a final MRA inspection, final approval and licensing for both medicinal and adult-use licenses will be granted. “Michigan’s two-step marijuana licensing process is one of the toughest in the country, and passing the scrutiny of state regulators for license prequalification should give our shareholders great confidence in our Michigan business plan,” said Hero Technologies CEO Gina Serkasevich in the press release. “The state of Michigan is also one of the fastest-growing cannabis markets in the nation, with monthly sales approaching $150 million in only the second year of legal operations, so our shareholders should also be excited about our near-term prospects for rapid growth.”

To view the full press release, visit https://cnw.fm/TLa86

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, please visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

You have probably heard of CBD, or cannabidiol, before. Extracted from cannabis or hemp, this chemical compound is said to have a wide variety of medical applications ranging from relieving pain and anxiety to treating seizures in epileptic patients. Thanks to its supposed medical potential, CBD can now be found in myriad wellness and health products, with the skincare industry especially taking a liking to the versatile hemp extract. But just how beneficial are these CBD-infused sunscreens, lip balms, moisturizers, lotions, masks and other skincare offerings?

According to Austin Kaz, a co-founder of New York-based Sheabrand, skincare product manufacturers add CBD to their products to give those products an extra kick, making them much more effective at treating skin conditions, including acne, eczema and dry skin. One of cannabidiol’s more well-known uses is as an anti-inflammatory agent, making it a great addition to products meant to address inflammatory skin conditions such as eczema, psoriasis and dermatitis. CBD does this by interacting with the receptors in the endocannabinoid system and reducing interleukins, which are cell-signaling molecules that can stimulate inflammation.

A couple of studies have found that CBD may have the ability to nourish and rejuvenate dry skin, subsequently reducing itching. Results from a study published in the March–April issue of  “Journal Clinical Therapeutics” show that CBD may be able to improve levels of skin hydration by moisturizing the skin and preventing it from losing water and boost skin elasticity. However, the researchers behind the study say this may be due to CBD’s anti-inflammatory properties or the fatty acids in the ointments the participants used, so more research with a much larger set of participants is needed.

Usually, dermatologists will prescribe topical steroidal creams, which act as anti-inflammatory agents, to treat some skin diseases. While these creams are perfectly safe and work great for most people, some individuals are not comfortable with using steroids of any kind. Robert Dellavalle, an adjunct professor of epidemiology at the Colorado School of Public Health, says that nonsteroidal therapies that use CBD can fill this gap. This type of therapy has also achieved promising results against a condition that affects millions of people from puberty well into adulthood: acne.

CBD’s anti-inflammatory properties combined with its influence on the production of sebum by skin cells via the CB2 receptors on the sebaceous glands make cannabinoid a potential therapy against acne. Additionally, research shows that topical CBD may be able to help kill gram-positive bacteria that are a known cause of acne. Finally, a CBD-infused sunscreen may help alleviate the effects of sunburns, such as redness.

However, do not look at CBD as a cure-all. Most of the evidence in its favor is anecdotal, and researchers say that even though preliminary studies have uncovered positive results, more research is needed. For the time being, do your homework on CBD, choose high-quality products and make sure you speak to your doctor before you use CBD, especially if you are pregnant or on other medication.

Companies such as Hero Technologies Inc. (OTC: HENC) focus on offering the benefits of CBD while making infused products addressing the skincare needs of their clients.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

The cannabis plant produces more than 100 compounds, among them CBD, which has been found to possess medical benefits. CBD and THC are the two main compounds produced by the cannabis plant. THC, or tetrahydrocannabinol, is what gives cannabis its psychoactive properties while CBD, or cannabidiol, makes up the plants’ healing properties. Other cannabinoids produced by the plant include CBN (cannabinol), CBC (cannabichromene) and CBG (cannabigerol).

Below, we look at CBD and CBG as well as their reported benefits.

What is CBG and CBD?

As mentioned above, CBD is one of the most common extracts derived from the cannabis plant. CBG is also an extract of the plant, but unlike CBD, it hasn’t been studied as extensively. Studies show that as the plant grows, most of the CBG is converted into other cannabinoids, including THC and CBD.

CBG and CBD oil are both nonpsychoactive oils that are extracted from cannabigerol and cannabidiol respectively. The most common techniques used to extract these oils are winterization and decarboxylation.

Decarboxylation involves using heat to separate a compound from a carboxyl group. For instance, CBD occurs in the marijuana plant as CBDA, or cannabidiol acid. This technique converts cannabidiol acid into CBD, which is its more active form.

After decarboxylation, the marijuana plant matter undergoes winterization, which is also known as fractionate crystallization. During this process, CBD oil and CBG oil are extracted from a mixture of other oils. This is dependent on the oils’ solubility, volatility and difference in melting points.

What are some of their health benefits?

• Help treat inflammation

Both oils can be used to relieve inflammation, as they contain properties that can be used to treat inflammatory conditions by impeding the inflammatory messenger activity in an individual’s body.

• Can relieve anxiety

Unlike CBG oil, CBD has been found to be effective in relieving anxiety by improving the body’s access to serotonin.

• Pain relief

Both CBG oil and CBD oil are effective in relieving pain, with a study that was conducted in 2018 finding that both substances relieved pain by improving the performance of pain-signaling receptors in the endocannabinoid system.

How are the two oils different?

Research has found that in addition to the health benefits mentioned above, CBG possesses neuroprotective properties that may be used to treat neurodegenerative disorders such as Huntington’s disease. CBG may also be used to relieve intraocular pressure, which makes it efficacious against glaucoma.

Furthermore, studies have shown that CBG also possesses antibacterial properties, which may be useful in eliminating methicillin-resistant Staphylococcus aureus, which causes drug-resistant staph infections.

With cannabis companies such as Hero Technologies Inc. (OTC: HENC) continuing to innovate, marijuana users are likely to see superior products leveraging the different attributes of many of the compounds in the cannabis plant as the years go by.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.